Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-09

FDA Approved: RILUZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's supplemental application for riluzole, authorizing the marketing of a generic riluzole product in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

SUPPL AP for RILUZOLE (RILUZOLE)